Skip to main content

Table 2 Crude and adjusted analysis of the association between sleep duration and cardiometabolic risk factors in adolescents. São Luís, Maranhão, Brazil, 2016/2017

From: Association between sleep duration and cardiometabolic factors in adolescents

Variables

Crude analysis

Adjusted analysis

 

β (95%IC)

p

β (95%IC)

p

Glycemia (mg/dL)

 Sleep duration

 

0.407

 

0.760

  ≥ 6 h

0

 

0a

 

  < 6 h

0.82(-1.11;2.75)

 

0.33(-1.80;2.47)

 

SBP (mmHg)

 Sleep duration

 

0.001

 

0.910

  ≥ 6 h

0

 

0b

 

  < 6 h

2.90(1.43;4.37)

 

-0.08(-1.50;1.34)

 

DBP (mmHg)

 Sleep duration

 

0.202

 

0.898

  ≥ 6 h

0

 

0b

 

  < 6 h

0.58(-0.31;1.48)

 

0.06(-0.92;1.05)

 

HDL-c (mg/dL)

 Sleep duration

 

0.145

 

0.286

  ≥ 6 h

0

 

0a

 

  < 6 h

-1.04(-2.44;0.36)

 

0.93(-0.78;2.63)

 

LDL-c (mg/dL)

 Sleep duration

 

0.036

 

0.303

  ≥ 6 h

0

 

0a

 

  < 6 h

-3.33(-6.45;-0.22)

 

-1.90(-5.51;1.71)

 

Total cholesterol (mg/dL)

 Sleep duration

 

0.098

 

0.941

  ≥ 6 h

0

 

0a

 

  < 6 h

-3.18(-6.94;0.59)

 

-0.16(-4.55;4.22)

 

Triglycerides (mg/dL)

 Sleep duration

 

0.308

 

0.969

  ≥ 6 h

0

 

0a

 

  < 6 h

2.98(-2.75;8.71)

 

0.13(-6.36;6.62)

 
  1. 95%IC 95% confidence interval; DBP Diastolic blood pressure; SBP systolic blood pressure; LDL-c low-density lipoprotein cholesterol; HDL-c high density lipoprotein cholesterol. aModel 1 = Adjusted for age, gender, adolescent years of study, skin color, economic class, current work, alcohol consumption, smoking, physical activity, screen time, food consumption; bModel 2 = Adjusted Model 1 + depression